ジャーナル
/
/
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
JoVE Journal
免疫学と感染
このコンテンツを視聴するには、JoVE 購読が必要です。  サインイン又は無料トライアルを申し込む。
JoVE Journal 免疫学と感染
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
DOI:

08:14 min

October 03, 2019

, , , , , , , ,

  • 00:04標題
  • 00:46Generation and Purification of Lentivirus Particles
  • 03:08Isolation and Transduction of Lineage-negative Cells from Mouse Bone Marrow
  • 05:23Transplantation of Transduced Cells into Lethally Irradiated Mice
  • 05:39Evaluating the Chimerism of Peripheral Blood
  • 06:19Results: Lentiviral Transduction of Mouse Bone Marrow Lineage-negative Cells
  • 07:23Conclusion

概要

自動翻訳

Described are protocols for the highly efficient genome editing of murine hematopoietic stem and progenitor cells (HSPC) by the CRISPR/Cas9 system to rapidly develop mouse model systems with hematopoietic system-specific gene modifications.

関連ビデオ

Read Article